Actemra

Actemra is a brand name medication that contains the active ingredient tocilizumab. It is a prescription drug that is primarily used to treat certain types of arthritis and other inflammatory conditions.

Actemra works by inhibiting the action of a protein called interleukin-6 (IL-6) in the body. This protein is known to be involved in the development of inflammation, and by blocking its action, Actemra can reduce the symptoms associated with various inflammatory diseases.

The drug is administered by injection either into a vein (intravenous) or under the skin (subcutaneous). The dosing frequency and method of administration will depend on the condition being treated and the individual patient’s needs.

Actemra has been approved for the treatment of moderate to severe rheumatoid arthritis, giant cell arteritis, and polyarticular juvenile idiopathic arthritis in patients who have not responded to other treatments. It is also used to treat systemic juvenile idiopathic arthritis, a rare condition that affects children and can cause inflammation in multiple organs.

As with all medications, Actemra can cause side effects, some of which can be serious. The most common side effects include upper respiratory tract infections, headaches, and increased blood pressure. Other potential side effects may include serious infections, liver damage, and allergic reactions.

Overall, Actemra is an important medication in the treatment of various inflammatory conditions. It is prescribed by doctors and administered under medical supervision to help manage the symptoms associated with these conditions and improve patients’ quality of life.